Saranas Announces Scheduled Presentations at TVT 2018 in Chicago

Scheduled presentations of interest include a moderated poster session by Philippe Généreux, MD, Saranas Chief Medical Officer and Co-Director of the Structural Heart Disease Program at Morristown Medical Center, Morristown, New Jersey, on Thursday, June 21 at 11:30 AM. Dr. Généreux will present results from the FDA-mandated validation study designed to assess the performance and safety of the Early Bird® Bleed Monitoring System.

Saranas Submits De Novo Application to FDA for the Early Bird® Bleed Monitoring System

Saranas Inc., a medical device company with innovative technology for real-time detection and monitoring of internal bleeding during endovascular procedures, today announced that it has submitted to the U.S. Food and Drug Administration (FDA) an application requesting Agency review and de novo classification of the Early Bird® Bleed Monitoring System.

Saranas’ Novel Bleed Monitoring System Receives Recognition in Cardiovascular Research Technologies 2018 Competition

Saranas, a medical device company with a cutting-edge technology for real-time detection and monitoring of internal bleeding during endovascular procedures, placed first runner-up at the Cardiovascular Research Technologies (CRT) competition on March 6, 2018, in Washington, D.C.

Saranas Named Finalist for Prestigious International Cardiovascular Innovation Award

Saranas, a medical device company with a new technology for real-time detection and monitoring of internal bleeding during endovascular procedures, today announced the company was named as one of the Top 4 Innovators at the International Conference for Innovations in Cardiovascular Systems (ICI) in Tel Aviv, Israel.

Saranas Invited to Present at TCT 2017 in Denver

Saranas, a medical device company with a new technology for real-time detection and monitoring of internal bleeding during endovascular procedures, has been invited to present at the 29th Transcatheter Cardiovascular Therapeutics (TCT) annual scientific symposium of the Cardiovascular Research Foundation (CRF), Oct. 31, 2017, in Denver, CO. Saranas was chosen to participate in the conference’s Shark Tank Competition.

Saranas Appoints Philippe Généreux, MD, as Chief Medical Officer

Saranas, a medical device company with a new technology for real-time detection of internal bleeding during cardiac procedures, today announced the appointment of Dr. Philippe Généreux as its Chief Medical Officer.